Remove Food and Drug Administration Remove Healthcare Remove Leads Remove Sales
article thumbnail

Icentia Receives U.S. Food and Drug Administration (FDA) Clearance for CardioSTAT®

Legacy MEDSearch

CardioSTAT has now become the leading wearable cardiac monitoring solution in Canada. The pay by duration model enables healthcare professionals to demonstrate cost savings while addressing a wide range of clinical needs. ”, said Pierre Paquet, co-founder and Chief Executive Officer at Icentia. Are you hiring?

article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. They relied so much on a new drug that they tried to market a product with bad science behind it. The pharma industry is a giant behemoth that needs new drugs to survive and grow.

Pharma 210
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Tasso+™ Device Earns FDA 510(k) Class II Medical Device Clearance

Legacy MEDSearch

the leading provider of convenient, clinical-grade blood collection solutions, announced that the U.S. Food and Drug Administration (FDA) has cleared its Tasso+ lancet as a Class II medical device. Tasso technology has the power to bring healthcare anywhere, any time. Tasso, Inc., About Tasso.

Medical 97
article thumbnail

Viatris to acquire Oyster Point and Famy Life Sciences

Pharmaceutical Technology

Oyster Point Pharma introduced Tyrvaya, a nasal spray approved by the Food and Drug Administration (FDA) to treat dry eye disease, in November last year. These acquisitions could possibly add a minimum of $1bn in sales of Viatris by 2028. Famy Life Sciences has an ophthalmology portfolio that complements Viatris.

article thumbnail

NeuroLogica Announces FDA 510(k) Clearance of BodyTom® 64

Legacy MEDSearch

Food and Drug Administration for commercial use in the United States. Director of Global Sales and Marketing of NeuroLogica. Trauma/ER: The BodyTom 64’s unique combination of internal lead shielding and battery operation allows any standard trauma bay to be transformed into an advanced CT imaging suite.

FDA 92
article thumbnail

Watch These 4 Large Drug Stocks Amid the Booming Industry

Contrarian Sales Techniques

The biotechnology and drug sectors performed well in the second half of 2022 after struggling in the first six months. Despite the uncertainty surrounding the global economy, the drug and biotechnology sectors have continued to perform well in the second half of 2022. This can lead to significant losses for large companies.

article thumbnail

Healthcare Watch July/August 2022

PM360

At this time, Juul can continue sales in the U.S., EPA Administrator Michael Regan said the agency will take more aggressive action against PFAS. People on the front-lines of PFAS contamination have suffered for far too long,” EPA Administrator Michael Regan said in a statement. Drug Approvals. FDA Update.